Hot Life Science Investor Mandate 1: State Fund Seeks Biotech R&D, Others for Allocations

26 Jul

A fund based in the Central United States, which has around $400 million under management, was set up by its state government in order to attract start up companies, and is currently seeking new investment opportunities in the life sciences space.

The majority of the funds investments (53%) are in the life sciences space, and since 2005, the fund has dedicated around $900 million to the sector. The fund typically invests in 10-20 companies a year, and their allocation size ranges from $250,000 to $5 million. The firm is most interested in the suppliers and engineering space, biotech therapeutics and diagnostics, and biotech R&D services. The firm is specifically interested in the medical devices space within the suppliers and engineering space, and is seeking firms focused on genomics in the biotech R&D space.

In terms of biotech therapeutics and diagnostics firms, the fund is fairly opportunistic in terms of subsector and indication, however does have a special interest in small molecules. The firm will consider pre-revenue firms, as well as firms that have products on the market. With that being said, the firm is agnostic in terms of the product’s development phase.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: